Dove Medical Press
academic publisher
Dove Medical Press is an academic publisher of open-access peer-reviewed scientific and medical journals, with offices in Macclesfield, London (United Kingdom); Princeton, New Jersey (United States); and Auckland (New Zealand). In September 2017, Dove Medical Press was acquired by the Taylor & Francis Group.
As an open access publisher, Dove charges a publication fee to authors or their institutions or funders. This charge allows Dove to recover its editorial and production costs and to create a pool of funds that can be used to provide fee waivers for authors from lesser developed countries. Articles published are available via an interface following the Open Archives Initiative Protocol for Metadata Harvesting, a set of uniform standards promulgated by the Open Archives Initiative allowing metadata on archive holdings.
Dove is a member of the Association of Learned and Professional Society Publishers, the Committee on Publication Ethics, and the Open Archives Initiative. As of March 2019, it published a total of 135 journals, although 43 have now ceased publication. In 2012, the company was included on Beall's List of predatory open-access publishers, was later removed, but was again included in this list in 2015.
History
Dove Medical Press is a privately held company founded in 2003 by Tim Hill, a former managing director of Adis International and five other founders.
As of 11 April 2013, 42 of the 131 journals were indexed in PubMed, while 30 of the 131 journals had fewer than ten articles.
This brief starts where responsible research should: with the source description of “Dove Medical Press” as academic publisher. Everything that follows is an evidence route, not borrowed authority.
Why this record matters
The subject matters to the general reference register because the source frames it as academic publisher. Its deeper value depends on whether names, dates, institutions and citations support that framing.
Named sources, stable identifiers and responsible institutions provide the strongest route from overview to verifiable evidence. The source revision retrieved here is dated Mar 20, 2026. The linked authority identifier is Q5302404. 2 of 2 selected statements include explicit references; 0 carry qualifiers and 0 use preferred rank. The first chronological checks are 2017, 2019, 2012 and 2015.
The absence of detail may reflect summary conventions rather than a lack of surviving documentation. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Dove Medical Press”, its source revision and the description used here.
- Expand the search: follow Dove Medical Press primary sources, Dove Medical Press archive and Dove research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Dove Medical Press”?
- Which institution is responsible for the underlying evidence?
- Which cited source is closest to the event, object or claim?
Search terms from this dossier
This entry incorporates text from “Dove Medical Press” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.